Board of Directors
Director, President and Chief Executive Officer
Dr. Merzouk holds a PhD in Organic Chemistry from University of Paris-Sud (Paris-XI), France. He has more than 18 years’ experience in industry and academia in drug discovery of small and large molecules.
Director, Executive Vice President and Chief Financial Officer
Dr. Ilsever is a retired Professor of Accounting, Finance and Statistical Measurement. He has extensive experience in the private sector in the issuance of fixed income securities and equities.
Director, Vice President, Regulatory Affairs and Drug Development
Dr. Yalloway has over 22 years of multidisciplinary research experience and skills in enzyme engineering, protein purification, and structural functional relationships of proteins of medical and industrial interest.